Canada first market for Crestor

October 27, 2003

AstraZeneca's Crestor is to receive an immediate launch in its first market after Canada's regulator's approved the new cholesterol lowering …

Mixed Paxil patent news for GSK

October 27, 2003

GlaxoSmithKline has received mixed news in the on-going patent battle with Canadian generics company Apotex over its biggest selling drug, …

Pfizer blockbuster to face competition

October 27, 2003

Pfizer's blockbuster hypertension and angina treatment Norvasc could face competition from a related drug following a US court ruling.A ruling …

Private sector invited to take over failing hospitals

October 27, 2003

The poorest performing NHS hospitals could now be run by private companies under new plans unveiled by the Government.Eight private …

NICE launches intervention assessment programme

October 27, 2003

The safety and efficacy of new surgical and non-surgical interventions are to be assessed as part of a new NICE …

Galen boosted by $295m Sarafem purchase

October 27, 2003

Galen has bolstered its product range by buying the rights to pre-menstrual syndrome treatment Sarafem from Lilly for $295 million.Shares …

ReNeuron in merger talks

October 24, 2003

Industry wins parallel import trademark case

October 24, 2003

A new UK High Court ruling has given pharma companies the right to block the sale of re-packaged parallel imports …

Three companies face US fraud lawsuits

October 24, 2003

Three pharmaceutical companies, GlaxoSmithKline, Pharmacia and Aventis, face legal action for alleged bribery and inflation of prescription drug prices in …

Smaller hospitals win Government support

October 24, 2003

Smaller local hospitals are to become important centres for developing patient-centred care in a reversal of what the Government calls …

14 more PCTs to join pharmaceutical services revolution

October 24, 2003

Fourteen PCTs have been given the go-ahead to develop new and innovative services and improve patient services through community pharmacists.Local …

J&J strengthens biotech business

October 24, 2003
Janssen, Janssen Cilag, Johnson & Johnson, Scios

 Johnson & Johnson is to expand its biotech capabilities with a $2.4 billion purchase of US company Scios.The deal, still …

vCJD caution prompts Serono product withdrawal

October 24, 2003

Serono is to withdraw one of its hormone products from the UK after a case of variant Creutzfeldt-Jakob disease was …

The Gateway to Local Adoption Series

Latest content